GlobalData on MSN10mon
Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea studyNyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback